-
Something wrong with this record ?
Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway
M. Handal, B. Nechanská, S. Skurtveit, IO. Lund, R. Gabrhelík, A. Engeland, V. Mravčík,
Language English Country United States
Document type Journal Article, Observational Study, Research Support, Non-U.S. Gov't
Grant support
NV16-28157A
MZ0
CEP Register
Digital library NLK
Full text - Article
NLK
Directory of Open Access Journals
from 2013
Free Medical Journals
from 2013
PubMed Central
from 2013
Europe PubMed Central
from 2013 to 2020
ProQuest Central
from 2013-10-01
Open Access Digital Library
from 2013-01-01
Open Access Digital Library
from 2013-01-01
Health & Medicine (ProQuest)
from 2013-10-01
Wiley Free Content
from 2013
Wiley-Blackwell Open Access Titles
from 2013
ROAD: Directory of Open Access Scholarly Resources
from 2013
PubMed
31428431
DOI
10.1002/prp2.501
Knihovny.cz E-resources
- MeSH
- Buprenorphine therapeutic use MeSH
- Adult MeSH
- Pregnancy Complications drug therapy MeSH
- Humans MeSH
- Logistic Models MeSH
- Methadone therapeutic use MeSH
- Young Adult MeSH
- Infant, Newborn MeSH
- Neonatal Abstinence Syndrome epidemiology MeSH
- Opiate Substitution Treatment MeSH
- Opioid-Related Disorders drug therapy MeSH
- Registries MeSH
- Pregnancy MeSH
- Child Development MeSH
- Prenatal Exposure Delayed Effects epidemiology MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Young Adult MeSH
- Infant, Newborn MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Observational Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
- Norway MeSH
There is lack of knowledge about the safety of treatment with methadone and buprenorphine as part of opioid maintenance treatment (OMT) during pregnancy. The purpose of this study was to examine neonatal outcomes concerning the use of OMT during pregnancy. We used nationwide registry linkages from the Czech Republic (2000-2014) and Norway (2004-2013). We compared prenatally OMT-exposed newborns with (a) newborns of women hospitalized with opioid use disorder during pregnancy in the Czech sample and (b) newborns with neonatal abstinence syndrome (NAS) in Norway. We performed multivariate linear and binary logistic regression exploring the associations between OMT and neonatal outcomes (growth parameters, gestational age, fetal death, small for gestational age, Apgar score, and NAS). Regression coefficients (b) and odds ratios (ORs) were estimated. The cohorts consisted of 333 Czech, and 235 Norwegian OMT-exposed newborns, and 106 and 294 newborns in the comparison groups, respectively. In both countries, the neonatal growth parameters were similar in the OMT and the comparison groups. In Norway, OMT exposure prolonged gestational age (adjusted b = 0.96 weeks, 95% confidence interval [CI] =0.39-1.53) while the odds of preterm birth and Apgar score at 5 minutes were lower than in the comparison group (adjusted OR = 0.35, 0.16-0.75 and aOR = 0.21, 0.06-0.78, respectively). Newborns of women in OMT had similar growth parameters as newborns of women with opioid use disorders who were not in OMT during pregnancy. Overall, our findings do not suggest that OMT results in worse neonatal outcomes.
Department of Addictology 1st Faculty of Medicine Charles University Prague Czech Republic
Department of Mental Disorders Norwegian Institute of Public Health Oslo Norway
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023744
- 003
- CZ-PrNML
- 005
- 20201214131030.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/prp2.501 $2 doi
- 035 __
- $a (PubMed)31428431
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Handal, Marte $u Department of Mental Disorders Norwegian Institute of Public Health Oslo Norway.
- 245 10
- $a Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway / $c M. Handal, B. Nechanská, S. Skurtveit, IO. Lund, R. Gabrhelík, A. Engeland, V. Mravčík,
- 520 9_
- $a There is lack of knowledge about the safety of treatment with methadone and buprenorphine as part of opioid maintenance treatment (OMT) during pregnancy. The purpose of this study was to examine neonatal outcomes concerning the use of OMT during pregnancy. We used nationwide registry linkages from the Czech Republic (2000-2014) and Norway (2004-2013). We compared prenatally OMT-exposed newborns with (a) newborns of women hospitalized with opioid use disorder during pregnancy in the Czech sample and (b) newborns with neonatal abstinence syndrome (NAS) in Norway. We performed multivariate linear and binary logistic regression exploring the associations between OMT and neonatal outcomes (growth parameters, gestational age, fetal death, small for gestational age, Apgar score, and NAS). Regression coefficients (b) and odds ratios (ORs) were estimated. The cohorts consisted of 333 Czech, and 235 Norwegian OMT-exposed newborns, and 106 and 294 newborns in the comparison groups, respectively. In both countries, the neonatal growth parameters were similar in the OMT and the comparison groups. In Norway, OMT exposure prolonged gestational age (adjusted b = 0.96 weeks, 95% confidence interval [CI] =0.39-1.53) while the odds of preterm birth and Apgar score at 5 minutes were lower than in the comparison group (adjusted OR = 0.35, 0.16-0.75 and aOR = 0.21, 0.06-0.78, respectively). Newborns of women in OMT had similar growth parameters as newborns of women with opioid use disorders who were not in OMT during pregnancy. Overall, our findings do not suggest that OMT results in worse neonatal outcomes.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a buprenorfin $x terapeutické užití $7 D002047
- 650 _2
- $a vývoj dítěte $7 D002657
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a logistické modely $7 D016015
- 650 _2
- $a methadon $x terapeutické užití $7 D008691
- 650 _2
- $a novorozenecký abstinenční syndrom $x epidemiologie $7 D009357
- 650 _2
- $a opiátová substituční terapie $7 D058850
- 650 _2
- $a poruchy spojené s užíváním opiátů $x farmakoterapie $7 D009293
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a komplikace těhotenství $x farmakoterapie $7 D011248
- 650 _2
- $a zpožděný efekt prenatální expozice $x epidemiologie $7 D011297
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 651 _2
- $a Norsko $x epidemiologie $7 D009664
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a pozorovací studie $7 D064888
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nechanská, Blanka $u Department of Addictology, First Faculty of Medicine Charles University Prague Czech Republic. Institute of Health Information and Statistics of the Czech Republic Prague Czech Republic.
- 700 1_
- $a Skurtveit, Svetlana $u Department of Mental Disorders Norwegian Institute of Public Health Oslo Norway. Norwegian Centre for Addiction Research at the University of Oslo Oslo Norway.
- 700 1_
- $a Lund, Ingunn Olea $u Department of Mental Disorders Norwegian Institute of Public Health Oslo Norway.
- 700 1_
- $a Gabrhelík, Roman $u Department of Addictology, First Faculty of Medicine Charles University Prague Czech Republic.
- 700 1_
- $a Engeland, Anders $u Department of Chronic Diseases and Ageing Norwegian Institute of Public Health Oslo Norway. Department of Global Public Health and Primary Care University of Bergen Bergen Norway.
- 700 1_
- $a Mravčík, Viktor $u Department of Addictology, First Faculty of Medicine Charles University Prague Czech Republic. National Monitoring Centre for Drugs and Addiction Office of the Government of the Czech Republic Prague Czech Republic.
- 773 0_
- $w MED00190080 $t Pharmacology research & perspectives $x 2052-1707 $g Roč. 7, č. 5 (2019), s. e00501
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31428431 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214131028 $b ABA008
- 999 __
- $a ok $b bmc $g 1596063 $s 1114420
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 7 $c 5 $d e00501 $e 20190814 $i 2052-1707 $m Pharmacology research & perspectives $n Pharmacol Res Perspect $x MED00190080
- GRA __
- $a NV16-28157A $p MZ0
- LZP __
- $a Pubmed-20201125